Pulmonary Hypertension and Anastrozole Trial
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Pulmonary Arterial Hypertension
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03229499
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Johns Hopkins University
- University of Colorado, Denver
- Rhode Island Hospital
- Stanford University
- Vanderbilt University
- Washington University School of Medicine
- Investigators
- Principal Investigator: Steven M Kawut, MD University of Pennsylvania
Get Well Soon